These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15126908)

  • 1. The SYST-EUR study and beyond: immediate versus delayed treatment of isolated systolic hypertension.
    van Zwieten PA;
    J Hypertens; 2004 Apr; 22(4):689-90. PubMed ID: 15126908
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.
    Staessen JA; Thijisq L; Fagard R; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Forette F; Leonetti G; McCormack P; Nachev C; O'Brien E; Rodicio JL; Rosenfeld J; Sarti C; Tuomilehto J; Webster J; Yodfat Y; Zanchetti A;
    J Hypertens; 2004 Apr; 22(4):847-57. PubMed ID: 15126928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators.
    Gasowski J; Staessen JA; Celis H; Fagard RH; Thijs L; Birkenhäger WH; Bulpitt CJ; Fletcher AE; Arabidze GG; de Leeuw P; Dollery CT; Duggan J; Kawecka-Jaszcz K; Leonetti G; Nachev C; Safar M; Rodico JL; Rosenfeld J; Seux ML; Tuomilehto J; Webster J; Yodfat Y
    J Hum Hypertens; 1999 Feb; 13(2):135-45. PubMed ID: 10100063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of antihypertensive treatment in the diabetic patients enrolled in the Systolic Hypertension in Europe (Syst-Eur) trial.
    Gasowski J; Birkenhäger WH; Staessen JA; de Leeuw PW
    Cardiovasc Drugs Ther; 2000 Feb; 14(1):49-53. PubMed ID: 10755200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial.
    Thijs L; Richart T; de Leeuw PW; Kuznetsova T; Grodzicki T; Kawecka-Jaszcz K; O'Brien E; Redón J; Birkenhäger WH; Fagard R; Staessen JA
    J Hypertens; 2010 Apr; 28(4):865-74. PubMed ID: 20051905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial.
    Birkenhäger WH; Staessen JA; Gasowski J; de Leeuw PW
    J Nephrol; 2000; 13(3):232-7. PubMed ID: 10928302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
    Forette F; Seux ML; Staessen JA; Thijs L; Babarskiene MR; Babeanu S; Bossini A; Fagard R; Gil-Extremera B; Laks T; Kobalava Z; Sarti C; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Birkenhäger WH;
    Arch Intern Med; 2002 Oct; 162(18):2046-52. PubMed ID: 12374512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blocker.
    Li CJ; Shi ZD
    Clin Ther; 2010 Feb; 32(2):396; author reply 397. PubMed ID: 20206797
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
    Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Also for problem cases; successful first line therapy].
    MMW Fortschr Med; 2005 Feb; 147(5):47. PubMed ID: 15766030
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists lower not only blood pressure. Arteriosclerosis is braked too].
    MMW Fortschr Med; 2001 Nov; 143(46):60. PubMed ID: 11759606
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of the SYST-EUR study. Isolated systolic hypertension and calcium antagonists].
    Faulhaber HD
    Fortschr Med; 1997 Nov; 115(32):45-6. PubMed ID: 9480267
    [No Abstract]   [Full Text] [Related]  

  • 15. Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial.
    Staessen JA; Thijs L; Celis H; Gasowski J; Wang JG; Fagard RH;
    S Afr Med J; 2001 Dec; 91(12):1060-8. PubMed ID: 11845604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An overview of hypertension studies with calcium antagonists].
    Kjeldsen SE; Midtbø K; Os I; Westheim A
    Tidsskr Nor Laegeforen; 1999 May; 119(13):1878-82. PubMed ID: 10382332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of antihypertensive drug treatment in elderly patients with isolated systolic hypertension.
    Wang JG; Staessen JA
    Neth J Med; 2001 Jun; 58(6):248-54. PubMed ID: 11395222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lacidipine. Aponil, Caldine, GR 43659, GR 43659X, GX 1048, Lacimen, Lacipil, Lacirex, Midotens, Motens, SN 305, Viapres.
    Drugs R D; 2002; 3(5):324-30. PubMed ID: 12455153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.